Good day and welcome to the Altimmune Year End 2017 Earnings Call. Today’s conference is being recorded. At this time, I would like to turn things over to Paul Arndt [ph]. Please go ahead.
|Paul Arndt||Investor Relations|
|Bill Enright||Chief Executive Officer|
|Elizabeth Czerepak||Chief Financial Officer and Executive Vice President, Corporate Development|
|Sybil Tasker||Chief Medical Officer|
|Scot Roberts||Chief Scientific Officer|
|Sarah Weber||Piper Jaffray|
Thank you, Kayla and thank you everyone for participating in today’s 2017 year end earnings conference call.